BACKGROUND
An increased risk of stroke has been reported in patients with migraine and headache. There is a lack of prospective data, however, on whether migraine is associated with hemorrhagic stroke, on the risk of ischemic stroke in women with migraine, and on the influence of aura on this risk.
OBJECTIVE
To examine whether migraine (with and without aura), headache, and nonmigrainous headache are associated with an increased risk of stroke (including ischemic or hemorrhagic subtypes) in women.
DESIGN AND INTERVENTION
Participants in the Women's Health Study, aged ≥45 years, completed questionnaires at baseline, 6 months, and yearly up to 10 years. Data were collected regarding self-reported history and features of migraine and headache during the past year and previously. Baseline data on migraine were analyzed with respect to demographics and association with stroke.
OUTCOME MEASURES
Outcome events were fatal and nonfatal stroke, which were classified as ischemic, hemorrhagic, or unknown (National Survey of Stroke criteria). Associations between all types of migraine or headache and stroke were calculated using a Cox proportional hazards model.
Are migraine and headache associated with an increased risk of stroke in women?

RESULTS
Among 39,754 study participants, 5,173 (13.0%) reported migraines during the year preceding study initiation, and 2,059 (39.8%) of the women experiencing migraines also reported symptoms of aura. History of migraine, but no migraine during the past year, was reported by 2,156 women (5.4%). At follow-up (mean 9 years), 385 strokes had occurred among all participants; of these, 309 were ischemic, 72 were hemorrhagic and 4 were undefined. There was no overall association between migraine or non migrainous headache and any type of stroke. In comparison with women without migraine, the migrainewith-aura subgroup had 1.5 times the risk of any stroke (hazard ratio [HR] 1.53, 95% CI 1.02-2.31) and 1.7 times the risk of ischemic stroke (HR 1.71, 95% CI 1.11-2.66), after adjustment for confounding variables. Migraine without aura was not associated with the risk of any stroke or with the risk of ischemic stroke. There was no asso ciation between migraine with or without aura and hemorrhagic stroke risk. In women aged <55 years, the risk of ischemic stroke was increased in patients with history of migraine during the previous year compared with those with no history of migraine (HR 1.63, 95% CI 1.05-2.54). In this younger group, the risk of any stroke was increased in women with migraine with aura compared with women without migraine (HR 1.75, 95% CI 1.02-3.00). In patients aged ≥55 years, migraine was not associated with the risk of any type of stroke.
CONCLUSION
The relative risks of both any stroke and ischemic stroke, but not the risk of hemorrhagic stroke, are increased in women with migraine with aura, particularly in those aged <55 years. The absolute risk increase, however, is low, with 3.8 additional cases per year per 10,000 women. The results show an increased risk of ischemic stroke in individuals who had experienced migraine with aura, particularly in those under the age of 55 years. The risk of ischemic stroke was not increased in migraine without aura or in nonmigrainous headache, and risk of hemorrhagic stroke was not increased in migraine with aura. This confirms the results of several previous studies 1 and emphasizes the complex reciprocal relationship between migraine with aura and stroke.
The mechanisms by which migraine with aura might lead to stroke are unknown. Migraine with aura is associated with an increased load of diffuse white-matter lesions on MRI, but their nature and relationship with stroke risk are unknown. In one MRI study, 2 small infarcts were more numerous only in the cerebellum, whereas Kurth et al. found that the vast majority of ischemic strokes occurred in the middle cerebral artery territory.
Vascular changes can accompany the migraine attack. Cortical spreading depression, the most likely cause of the aura, induces a reduction in regional cerebral blood that could accentuate other risk factors for stroke. The spreading OLIGEMIA of migraine with aura is, however, essentially occipito-parietal, and MIGRAINOUS STROKE is a very rare event.
Migraine is associated with a higher prevalence of risk factors for stroke, such as hypertension and elevated cholesterol, 3 but the increased risk of ischemic stroke in migraine with aura persists even after controlling for other major stroke risk factors.
The prevalence of PATENT FORAMEN OVALE (PFO) is also increased in migraine with aura, as confirmed in a recent cross-sectional case-control study. 4 Whether PFO is causally related to migraine with aura or just comorbid with it for genetic reasons, and whether stroke incidence is higher in migraine patients with PFO, remains to be determined.
The mitochondrial energy reserve in migraine patients is decreased by 20% between attacks, and this could have a role in migraine pathogenesis. 5 Although it is admittedly much more severe, the abnormal mitochondrial energy metabolism that occurs in mitochondrial cytopathies, such as MELAS, leads to stroke and migraine.
What are the practical consequences of the migraine-stroke risk association? The main priority is to avoid panic among patients. Even in the migraine-with-aura patient subgroup, the absolute risk increase is considerably lower (3.8 additional strokes per 10,000 women per year in Kurth et al.'s study) than for other known stroke risk factors. Nonetheless, it is important to manage additional stroke risk factors, such as hypertension, hypercholesterolemia, smoking and estrogen therapy, especially in young patients (<55 years) who have migraine with aura. Moreover, large controlled prospective studies are required to establish which preventive anti-migraine therapies are able to decrease the stroke risk and the white matter lesions appearing on brain MRI. Anti-migraine drugs able to reduce cerebral vasospasm, inhibit thrombosis or increase mitochondrial metabolism are intuitively expected to have better effects than other anti-migraine medications. 
PRACTICE POINT
Migraine with aura slightly increases the risk of ischemic stroke; optimal control of other risk factors is therefore necessary, as is the identification of preventive treatments that reduce this risk
